Researchers found no detectable levels of semaglutide in breast milk, suggesting minimal risk to breastfed infants, but highlighted the need for monitoring maternal nutrition and milk production.
Augmedix Expands AI Solutions to Behavioral Health Market
What You Should Know: – Augmedix announced today the expansion of the company’s ambient medical documentation products to the behavioral healthcare market. Augmedix currently supports behavioral healthcare entities